510(k) device
NP1 Instrument, Creo Electrosurgical System
Creo Medical, Ltd. · System, Ablation, Microwave And Accessories (NEY, Class II) · First FDA decision Oct 28, 2020, newest Oct 28, 2020Tumor ablation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "NP1"
MAUDE reports
29
Brand "NP1", since 2015
PubMed studies
857
Mentioning "NP1"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NP1 Instrument, Creo Electrosurgical System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K200003 · Decided Oct 28, 2020 · 300 days after receipt
Device type: System, Ablation, Microwave And Accessories (NEY) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NP1", any status and sponsor, newest update first.
No registered device study names "NP1".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NP1", and for the whole product code for context.
This brand
29 reports: 26 malfunction, 3 injury, 0 death
Whole product code NEY
1,658 reports: 944 malfunction, 667 injury, 43 death
Newest reports for this brand
- WM-NP1 110-120V EXERA II CARTMalfunction
KeyMed (Medical and Industrial Equipment) Ltd.
9611174-2026-00223 · Received Oct 8, 2026 · Event dated Sep 11, 2026
Device type: Accessories, Photographic, For Endoscope (Exclude Light Sources) (FEM)
Device problem as coded: Break; Detachment of Device or Device Component
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- WM-NP1 110-120V EXERA II CARTMalfunction
KEYMED (MEDICAL AND INDUSTRIAL EQUIPMENT) LTD.
9611174-2025-00215 · Received Jul 7, 2025
Device type: Accessories, Photographic, For Endoscope (Exclude Light Sources) (FEM)
Device problem as coded: Break
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- WM-NP1 110-120V EXERA II CARTMalfunction
KEYMED (MEDICAL AND INDUSTRIAL EQUIPMENT) LTD.
9611174-2024-01709 · Received Dec 16, 2024 · Event dated Nov 19, 2024
Device type: Accessories, Photographic, For Endoscope (Exclude Light Sources) (FEM)
Device problem as coded: Break
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "NP1"[tiab]. The summary above synthesizes these.
- Human bocavirus NP1 antagonizes host type I interferon response through repressing the nuclear transport of STAT1.
Xue M, Huang C, Jiang X, et al. · Virulence · 2025
- A novel cyclic NP1 reveals obstruction of EGFR kinase activity and attenuation of EGFR-driven cell lines.
Jiwacharoenchai N, Tabtimmai L, Kiriwan D, et al. · J Cell Biochem · 2022Research Support, Non-U.S. Gov't
- Human Bocavirus 1 NP1 acts as an ssDNA-binding protein to help AAV2 DNA replication and cooperates with RPA to regulate AAV2 capsid expression.
Zhao Y, Liu W, Li Y, et al. · J Virol · 2024Research Support, Non-U.S. Gov't
- N4-acetylcytidine coordinates with NP1 and CPSF5 to facilitate alternative RNA processing during the replication of minute virus of canines.
Zhang X, Qin S, Huang F, et al. · Nucleic Acids Res · 2025Research Support, Non-U.S. Gov't
- Compression strategies for large-scale electrophysiology data.
Buccino AP, Winter O, Bryant D, et al. · J Neural Eng · 2023
- Neuronal pentraxins modulate cocaine-induced neuroadaptations.
Pacchioni AM, Vallone J, Worley PF, et al. · J Pharmacol Exp Ther · 2009Research Support, N.I.H., Extramural
- The Human Bocavirus 1 NP1 Protein Is a Multifunctional Regulator of Viral RNA Processing.
Dong Y, Fasina OO, Pintel DJ · J Virol · 2018Research Support, N.I.H., Extramural
- The small nonstructural protein NP1 of human bocavirus 1 directly interacts with Ku70 and RPA70 and facilitates viral DNA replication.
Ning K, Wang Z, Cheng F, et al. · PLoS Pathog · 2022Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- NP1 Protein of the Bocaparvovirus Minute Virus of Canines Controls Access to the Viral Capsid Genes via Its Role in RNA Processing.
Fasina OO, Dong Y, Pintel DJ · J Virol · 2016Research Support, N.I.H., Extramural
- [In utero fetal death].
Quibel T, Bultez T, Nizard J, et al. · J Gynecol Obstet Biol Reprod (Paris) · 2014Review
- Porcine bocavirus NP1 negatively regulates interferon signaling pathway by targeting the DNA-binding domain of IRF9.
Zhang R, Fang L, Wang D, et al. · Virology · 2015Research Support, Non-U.S. Gov't
- Complete genome sequence of Bradyrhizobium NP1, isolated from forest soil.
Fisher T, Durmazolu F, DeAngelis KM, et al. · Microbiol Resour Announc · 2023
Other devices of this type
Also filed under product code NEY.
- Emprint Ablation System with Thermosphere TechnologyCovidien, LLC · 510(k) 2020
- Certus 140 2.45GHz Ablation SystemNeuwave Medical, Inc. · 510(k) 2018
- Microwave Ablation AntennasCanyon Medical, Inc. · 510(k) 2026
- swiftPro System (SWF-SPS)Emblation Limited · 510(k) 2025
- NEUWAVE Microwave Ablation System and AccessoriesNeuwave Medical, Inc. · 510(k) 2023
- Solero Microwave Tissue Ablation (MTA) System and AccessoriesAngioDynamics, Inc. · 510(k) 2023
- miraDry SystemMiramar Labs, Inc. · 510(k) 2018
- Microsurgeon Microwave Tissue Ablation Device, Model MTAD-200Microsurgeon, Inc. · 510(k) 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.